Prescribed and non-prescribed gabapentin use among persons seeking inpatient opioid detoxification
Journal of Substance Abuse Treatment Dec 19, 2019
Stein MD, et al. - Researchers sought predictors of ever using gabapentin among persons seeking treatment for opioid use. In addition, they investigated reasons for gabapentin use by gender and how gabapentin was procured (prescribed, non-prescribed, or both). From a managed withdrawal program, they recruited 401 persons with opioid use disorder (69.1% male, 84.5% White, 86.8% sought treatment for heroin use, 90.0% insured). The majority of the participants reported a history of gabapentin use, with most using diverted gabapentin. Overall, males and females had similar reasons for use among those reporting a history of gabapentin use (65.8%), although males were more likely to use to get high than females. The analysis revealed the correlation of education, injection drug use, overdose, and chronic pain with gabapentin use (65.8%). Categorization of gabapentin acquisition was done as follows: non-prescribed (47%), prescribed (21%) or both (33%). The primary prescription of gabapentin was observed for controlling pain (81.5%). The use of non-prescribed gabapentin was most commonly observed in correlation to the following reasons: get high, increase the effects of heroin, substitute for opioids, and help with opioid withdrawal.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries